HansaBioMed Life Sciences

Towards EV-Based Therapeutics: New Project Grant Awarded

E
By Editorial Team
1 min read
PANACEA/EVs project funded by Enterprise Estonia

We are pleased to announce that our research project PANACEA/EVs (Potency Assay and Novel Avenues for Clinical Evaluation of AngioARC or derived EV-based Therapeutics) is awarded 1M EUR in funding. 

Through this project, in collaboration with Cellin Technologies we will contribute to the advancement of potency assessment and clinical evaluation of EV-based therapeutics.

Share this article: